U.S. govt to buy 10 million courses of Pfizer's COVID-19 pill for $5.29
billion
Send a link to a friend
[November 18, 2021]
(Reuters) -Pfizer
Inc said on Thursday the U.S. government had signed a $5.29 billion deal
for 10 million courses of its COVID-19 oral antiviral drug for delivery
by 2022. |
![](../images/111821PIX/news_I15.jpg)
Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen
manufactured in Ascoli, Italy, in this undated handout photo obtained by
Reuters on November 16, 2021. Pfizer/Handout via REUTERS |
If
authorized, Pfizer said it would supply the drug beginning later
this year and concluding in 2022.
"This promising treatment could help accelerate our path out of
this pandemic by offering another life-saving tool for people
who get sick with COVID-19," said Xavier Becerra, secretary of
the United States Department of Health and Human Services.
(Reporting by Manas Mishra in Bengaluru; Editing by Ramakrishnan
M.)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
![](column_spacer.png)
|
|
|